Department of Bioengineering, University of California, San Diego, 9500 Gilman Drive, La Jolla, CA 92093, USA.
Materials Science and Engineering Program, University of California, San Diego, 9500 Gilman Drive, La Jolla, CA 92093, USA.
Adv Drug Deliv Rev. 2018 Jul;132:235-251. doi: 10.1016/j.addr.2018.06.011. Epub 2018 Jun 21.
3D bioprinting is emerging as a promising technology for fabricating complex tissue constructs with tailored biological components and mechanical properties. Recent advances have enabled scientists to precisely position materials and cells to build functional tissue models for in vitro drug screening and disease modeling. This review presents state-of-the-art 3D bioprinting techniques and discusses the choice of cell source and biomaterials for building functional tissue models that can be used for personalized drug screening and disease modeling. In particular, we focus on 3D-bioprinted liver models, cardiac tissues, vascularized constructs, and cancer models for their promising applications in medical research, drug discovery, toxicology, and other pre-clinical studies.
3D 生物打印技术作为一种新兴的技术,具有将具有特定生物成分和机械性能的复杂组织构建体进行定制的潜力。最近的进展使科学家能够精确地定位材料和细胞,以构建用于体外药物筛选和疾病建模的功能性组织模型。本综述介绍了最先进的 3D 生物打印技术,并讨论了用于构建可用于个性化药物筛选和疾病建模的功能性组织模型的细胞来源和生物材料的选择。特别是,我们关注 3D 生物打印的肝脏模型、心脏组织、血管化构建体和癌症模型,因为它们在医学研究、药物发现、毒理学和其他临床前研究中有很好的应用前景。